Mycology

Colorado To Vote On Psilocybin Legalization Next Month

Psychedelic mushrooms are already decimalized in Denver

Colorado voters next month will decide whether to legalize psilocybin and psilocin, the psychoactive compounds found in what is colloquially known as magic mushrooms, for therapeutic purposes, Colorado News Online reports. If approved, the Natural Medicine Act – or Proposition 122 – would also decriminalize personal possession of the fungi and allow people to grow their own. 

The measure would allow licensed “healing centers” to provide psilocybin and psilocyn for therapeutic purposes. 

Natural Medicine Colorado, the group backing the effort, told Colorado News Online that “Natural psychedelic medicines are non-addictive and can have profound benefits for people struggling with challenging mental health conditions including depression and anxiety and those struggling to find peace at the end of their lives.” 

An issue committee supporting the reforms reported more than $2.8 million in contributions, with nearly all of that funding coming from Washington, D.C.-based New Approach PAC, according to campaign finance disclosures outlined by Colorado News Online. New Approach PAC also supported the successful natural psychedelic decriminalization measures in Oregon and Washington, D.C., in 2020. Psychedelic mushrooms are already decimalized in Denver, which approved a measure in 2019 to make possession of the substances the city’s “lowest law enforcement priority.” 

To Read The Rest Of This Article On Ganjapreneur, Click Here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

  • Exotic Blvd

CHAMPS Smoke Shop Report, or ‘CSS’, online source for the updates and innovations on the smoke shop scene. News and information are geared strictly to accessories retail channels, with distribution limited to retailers that Smoke Shop products and wholesalers.

Newsletter

Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!


To Top